Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.48.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.28.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.93 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.312NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.220NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.142NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.523NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.418NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.389NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.363NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.405NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.282NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.228NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.174NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.88 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.106 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used